The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen.
Saved in:
| Title: | The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen. |
|---|---|
| Authors: | Safgren SL; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Suman VJ; Division of Quantitative Health Sciences, Department of Health Sciences, Mayo Clinic, Rochester, MN, USA., Leon Ferre RA; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Kosel ML; Division of Quantitative Health Sciences, Department of Health Sciences, Mayo Clinic, Rochester, MN, USA., Stearns V; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Henry NL; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA., Denduluri N; AstraZeneca, Arlington, VA, USA., Irvin W; Bon Secours Mercy Health, Bon Secours Cancer Institute, Midlothian, VA, USA., Ingle JN; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Sideras K; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA., Ames MM; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Reid JM; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Loprinzi CL; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA., Black JL; Division of Laboratory Genetics and Genomics, Personalized Genomics Laboratory, Mayo Clinic Laboratories, Mayo Clinic, Rochester, MN, USA., Weinshilboum RM; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA., Goetz MP; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA. Goetz.Matthew@mayo.edu. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2025 May; Vol. 211 (1), pp. 261-270. Date of Electronic Publication: 2025 Feb 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40011368 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Safgren+SL%22">Safgren SL</searchLink>; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.<br /><searchLink fieldCode="AU" term="%22Suman+VJ%22">Suman VJ</searchLink>; Division of Quantitative Health Sciences, Department of Health Sciences, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Leon+Ferre+RA%22">Leon Ferre RA</searchLink>; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.<br /><searchLink fieldCode="AU" term="%22Kosel+ML%22">Kosel ML</searchLink>; Division of Quantitative Health Sciences, Department of Health Sciences, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Stearns+V%22">Stearns V</searchLink>; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Henry+NL%22">Henry NL</searchLink>; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.<br /><searchLink fieldCode="AU" term="%22Denduluri+N%22">Denduluri N</searchLink>; AstraZeneca, Arlington, VA, USA.<br /><searchLink fieldCode="AU" term="%22Irvin+W%22">Irvin W</searchLink>; Bon Secours Mercy Health, Bon Secours Cancer Institute, Midlothian, VA, USA.<br /><searchLink fieldCode="AU" term="%22Ingle+JN%22">Ingle JN</searchLink>; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.<br /><searchLink fieldCode="AU" term="%22Sideras+K%22">Sideras K</searchLink>; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USA.<br /><searchLink fieldCode="AU" term="%22Ames+MM%22">Ames MM</searchLink>; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.<br /><searchLink fieldCode="AU" term="%22Reid+JM%22">Reid JM</searchLink>; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Loprinzi+CL%22">Loprinzi CL</searchLink>; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA.<br /><searchLink fieldCode="AU" term="%22Black+JL%22">Black JL</searchLink>; Division of Laboratory Genetics and Genomics, Personalized Genomics Laboratory, Mayo Clinic Laboratories, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Weinshilboum+RM%22">Weinshilboum RM</searchLink>; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Goetz+MP%22">Goetz MP</searchLink>; Department of Oncology, Mayo Clinic, 200 1st Street SW, Rochester, MN, 55905, USA. Goetz.Matthew@mayo.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2025 May; Vol. 211 (1), pp. 261-270. <i>Date of Electronic Publication: </i>2025 Feb 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40011368 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10549-025-07644-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 261 Titles: – TitleFull: The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Safgren SL – PersonEntity: Name: NameFull: Suman VJ – PersonEntity: Name: NameFull: Leon Ferre RA – PersonEntity: Name: NameFull: Kosel ML – PersonEntity: Name: NameFull: Stearns V – PersonEntity: Name: NameFull: Henry NL – PersonEntity: Name: NameFull: Denduluri N – PersonEntity: Name: NameFull: Irvin W – PersonEntity: Name: NameFull: Ingle JN – PersonEntity: Name: NameFull: Sideras K – PersonEntity: Name: NameFull: Ames MM – PersonEntity: Name: NameFull: Reid JM – PersonEntity: Name: NameFull: Loprinzi CL – PersonEntity: Name: NameFull: Black JL – PersonEntity: Name: NameFull: Weinshilboum RM – PersonEntity: Name: NameFull: Goetz MP IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2025 May Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1573-7217 Numbering: – Type: volume Value: 211 – Type: issue Value: 1 Titles: – TitleFull: Breast cancer research and treatment Type: main |
| ResultId | 1 |